References in periodicals archive ?
Twelve sural nerve biopsies with hereditary neuropathy with liability to pressure palsy (HNPP) were included in the study
In this study we aimed to compare vasculitic neuropathy and axonal neuropathy without an identifiable cause because both groups show axonal degeneration in their pathology and a demyelinating hereditary neuropathy HNPP as a control group.
The computer pallesthesiometry method can be widely used in clinical practice for diagnostics of hereditary neuropathies with genetically determined pathology of myelin sheath (myelinopathy), including CMT, hereditary neuropathy with liability to pressure palsies, Dejerine-Sottas disease.
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 and hereditary neuropathy with liability to pressure palsies: a European collaborative study.
PMP22 related neuropathies: Charcot-Marie-Tooth disease type 1A and Hereditary Neuropathy with liability to pressure palsies.
Estimation of the mutation frequencies in Charcot-Marie-Tooth disease type 1 (CMT1) and hereditary neuropathy with liability to pressure palsies (HNPP): a European collaborative study.
However, absence of skin lesions and thickened nerves, negative slit skin smears and perhaps a family history suggestive of a hereditary neuropathy, could suggest the correct diagnosis.
A clinically distinct hereditary neuropathy with liability to pressure palsy (HNPP) has been found allelic to CMT1A, in which deletion of the same 1.
Two examples of diseases caused by alterations in gene dosage are the autosomal dominant demyelinating peripheral neuropathy Charcot-Marie-Tooth disease type 1A (CMT1A) [1] and hereditary neuropathy with liability to pressure palsies (HNPP).
Two well-documented diseases known to be caused by gene copy number alterations are the hereditary peripheral neuropathies Charcot-Marie-Tooth type 1A (CMT1A) [1] and hereditary neuropathy with liability to pressure palsies (HNPP).
2-kb region of the Charcot-Marie-Tooth disease type 1A repeat sequence: new tools for molecular diagnosis of hereditary neuropathy with liability to pressure palsies and of Charcot-Marie-Tooth disease type 1A.

Full browser ?